The US Food and Drug Administration (FDA) has approved Dovato, a new single-tablet antiretroviral regimen containing the HIV integrase inhibitor dolutegravir (sold...HIV/AIDS
Virological response rates were excellent among patients receiving second-line antiretroviral therapy (ART) based on dolutegravir, even when regimens included a...South Africa
South Africa’s recently awarded antiretroviral (ARV) tender, worth around R14bn over three years, is probably the biggest change since the single once daily tablet for...Weekly Roundup
South African drug-maker Aspen Pharmacare has launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent, reports...International
The European Medicines Agency’s risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and quinolone following...HIV/AIDS
A large study by French researchers at CHU de Martinique, INSERM UMR 1027 - Toulouse, Nice University Hospital, Pitié Salpetrière University Hospital, Paris, Marseille...Weekly Roundup
GlaxoSmithKline (GSK) is taking its fight with Gilead Sciences for dominance of the HIV market to the world’s leading Aids conference in July by showcasing detailed...HIV/AIDS
ViiV Healthcare has released data from two phase 3 trials that showed a once-daily, two-drug regimen of dolutegravir and lamivudine was non-inferior to a standard...
May 23rd, 2018The US Food and Drug Administration (FDA) has issued a safety alert warning patients and providers about a potential risk for neural tube birth defects in babies born to...
An estimated 2,000 new HIV infections occur in young women and girls every week in South Africa. Now, says Health-e News, a joint Spotlight/Health-e News Service special...
